Pacemakers for Slow Heart Rate and Statins for Low LDL Cholesterol

By
estaff
-
Published:
0
Two leadless pacemakers (Micra and Nanostim) have had several years of testing. Both have been approved in Europe, and the Micra was approved in the U.S. in April 2016. When we prescribe a statin we are not just treating the numbers but targeting cardiovascular (CV) risk, with the primary aim of reducing heart attack and stroke. Whether to start statin therapy is dependent more on whether you fit into a high-risk group for developing CV events rather than the specific cholesterol numbers.
To continue reading this article or issue you must be a paid subscriber. Sign in
Subscribe

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access

RELATED ARTICLESMORE FROM AUTHOR